Abstract | OBJECTIVE: DESIGN: All consecutive women with histologically documented endometrial hyperplasia without atypia recruited during a 1-year period participated in an open, prospective, single-center study. They were followed for at least 2 years after levonorgestrel-releasing intrauterine system insertion. The pattern of uterine bleeding was evaluated on a 4-point qualitative scale (1 = amenorrhea, 2 = scarce, 3 = normal, 4 = abundant). RESULTS: The study population consisted of 15 women with a mean (SD) age of 49 (2.7) years. Compared with baseline, bleeding decreased quantitatively from a mean score of 3 at baseline (normal bleeding) to 2 (scarce) at 3and 6 months, and 1 ( amenorrhea) at 24 months. Endometrial biopsies performed at 12 months revealed atrophicendometrium in 14 women (93.3%) and secretory endometrium in 1 (6.7%) (P < 0.001). At 24 months, endometrial atrophy was documented in 100% of women. CONCLUSIONS:
|
Authors | Sergio Haimovich, Miguel A Checa, Gemma Mancebo, Pere Fusté, Ramón Carreras |
Journal | Menopause (New York, N.Y.)
(Menopause)
2008 Sep-Oct
Vol. 15
Issue 5
Pg. 1002-4
ISSN: 1530-0374 [Electronic] United States |
PMID | 18451744
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Contraceptive Agents, Female
- Levonorgestrel
|
Topics |
- Adult
- Contraceptive Agents, Female
(therapeutic use)
- Endometrial Hyperplasia
(drug therapy)
- Endometrium
(drug effects)
- Female
- Follow-Up Studies
- Humans
- Intrauterine Devices, Medicated
- Levonorgestrel
(therapeutic use)
- Menstruation
(drug effects)
- Middle Aged
- Perimenopause
- Postmenopause
- Prospective Studies
- Spain
- Treatment Outcome
|